Granulocyte-colony stimulating factor inhibits inducible nitric oxide synthase gene expression in pulmonary epithelial cells in vitro

European Journal of Pharmacology

Volumn 358, Issue 2, 1998, Pages 169-176

  Hoffmann, Georg ^a   Schobersberger, Wolfgang ^b  

^a UNIVERSITY OF BONN   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cytokine; Endotoxin shock; Inflammatory mediator; Nitric oxide (NO)

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DRUG EFFECT; GENE EXPRESSION; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELLS, CULTURED; DRUG INTERACTIONS; ENZYME INDUCTION; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRANULOCYTE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; LUNG; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; RNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031717468     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00565-2     Document Type: Article

References (39)

1. Adcock I.M., Brown C.R., Kwon O.J., Barnes P.J. Oxidative stress induces NFκB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem. Biophys. Res. Commun. 199:1994;1518-1524.
2. Avalos B.R., Gasson J.C., Hedvat C., Quan S.G., Baldwin G.C., Weisbart R.H., Williams R.E., Golde D.W., DiPersio J.F. Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood. 75:1990;851-857.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 72:1976;148-154.
4. Bussolino F., Wang J.M., Defilippi P., Turrini F., Sanavio F., Edgell C.J., Aglietta M., Arese P., Mantovani A. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature. 337:1989;471-473.
5. Cairo M.S., Mauss D., Kommareddy S., Norris K., Van de Ven C., Mondanlou H. Prophylactic or simultaneous administration of recombinant human granulocyte colony-stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr. Res. 27:1990;612-616.
6. Cairo M.S., Plunkett J.M., Mauss D., Van de Ven C. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutropenia, myelopoiesis and group B Streptococcus sepsis. Blood. 76:1990;1788-1794.
7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 62:1987;156-159.
8. Cremona G., Higenbottam T., Takao M., Hall L., Bower E.A. Exhaled nitric oxide in isolated pig lungs. J. Appl. Physiol. 78:1995;59-63.
9. Dale D.C., Liles W.C., Summer W.R., Nelson S. Review: granulocyte colony-stimulating factor - role and relationships in infectious diseases. J. Infect. Dis. 59:1995;1557-1563.
10. Douglas W.H.J., Farrell P.M. Isolation of cells that retain differential functions in vitro: properties of clonally isolated type II alveolar pneumocytes. Environ. Health Perspective. 16:1976;83-89.
11. Evans, T.J., Cohen, J., 1996. Mediators: nitric oxide and other toxic oxygen species. In: Rietschel, E.T., Wagner, H. (Eds.), Current Topics in Microbiology and Immunology, Vol. 216. Pathology of Septic Shock. Springer Press, Berlin, pp. 189-207.
12. Fein A.M., Lippmann M., Holtzman H., Eliraz A., Goldberg S.K. The risk factors, incidence, and prognosis of ARDS following septicemia. Chest. 1:1983;40-41.
13. Fink M.P., O'Sullivan B.P., Menconi M.J., Wollert S.P., Wang H., Youssef M.E., Bellelsle J.M. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J. Trauma. 34:1993;571-578.
14. Görgen I., Hartung T., Leist M., Niehörster M., Tiegs G., Uhlig S., Weitzel F., Wendel A. Granulocyte colony-stimulating factor treatment protect rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α J. Immunol. 149:1992;918-924.
15. 15N] nitrate in biological fluids Anal. Biochem. 126:1982;131-138.
16. Gustafson L.E., Leone A.M., Persson M.G., Wiklund N.P., Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 181:1991;852-857.
17. Gutierrez H.H., Pitt B.R., Schwarz M., Watkin S.C., Lowenstein C., Caniggia I., Chumley P., Freeman B.A. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am. J. Physiol. 12:1995;L501-L508.
18. Haddad I.Y., Crow J.P., Hu P., Ye Y., Beckman J.S., Matalon S. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am. J. Physiol. 267:1994;L242-L249.
19. Haddad I.Y., Zhu S., Crow J.P., Barefield E., Gadilhe T., Matalon S. Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am. J. Physiol. 270:1996;L898-L906.
20. Hoffmann G., Grote J., Friedrich F., Mutz N., Schobersberger W. The pulmonary epithelial cell line L2 as a new model for an inducible nitric oxide synthase expressing distal airway epithelial cell. Biochem. Biophys. Res. Commun. 217:1995;575-583.
21. Hoppe-Seyler F., Butz K., Rittmüller C., Von Knebel Döberitz M. A rapid microscale procedure for the simultaneous preparation of cytoplasmic RNA, nuclear DNA binding proteins and enzymatically active luciferase extracts. Nucleic Acids Res. 19:1991;5080.
22. Hu P., Ischiropoulos H., Beckman J.S., Matalon S. Peroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells. Am. J. Physiol. 266:1994;L628-L634.
23. Kanazawa M., Ishizaka A., Hasegawa N., Suzuki Y., Yokoyama T. Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am. Rev. Respir. Dis. 145:1992;1030-1035.
24. Laemmli U.K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
25. Lyons C.R., Orloff G.F., Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267:1992;6370-6374.
26. Miles P.R., Bowman L., Huffman L. Nitric oxide alters metabolism in isolated alveolar type II cells. Am. J. Physiol. 271:1996;L23-L30.
27. Nelson S., Fotheringham N., Movahhed H. Filgrastim reduces adult respiratory distress syndrome and other serious complications in patients with multilobar pneumonia. Eur. Respir. J. 9(Suppl. 23):1996.
28. Nelson S., Farkas S., Fotheringham N., Marrie T., Movahhed H. Filgrastim in the treatment of hospitalized patients with community acquired pneumonia. Am. J. Respir. Crit. Care Med. 153:1996;A535.
29. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
30. Platzer C., Ode-Hakim S., Reinke P., Doecke W.D., Ewert R., Volk H.D. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation. 58:1994;264-268.
31. Punjabi C.J., Laskin J.D., Pendino K.J., Goler N.L., Durham S.K., Laskin D.L. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am. J. Respir. Cell. Mol. Biol. 11:1994;165-172.
32. Robbins R.A., Springall D.R., Warren J.B., Kwon O.J., Buttery L.D.K., Wilson A.J., Adcock I.M., Riveros-Moreno V., Moncada S., Polak J., Barnes P.L. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem. Biophys. Res. Commun. 198:1994;835-843.
33. Schobersberger W., Hoffmann G., Grote J., Wachter H., Fuchs D. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Lett. 377:1995;461-464.
34. 2+ currents in alveolar epithelial cells. Am. J. Physiol. 272:1997;L1092-L1097.
35. Siebert P.D., Larrick J.W. Competitive PCR. Nature. 359:1992;557-558.
36. Tweardy, D.J., Burkhardt, A.L., Bolen, J., Geahlen, R.L., Corey, S.J., 1993. G-CSF receptor signaling involves SRC-related and non-SRC-related tyrosine kinases with evidence of a three-component complex. In: Abraham, N.G., Shadduck, R.K., Levine, A.S., Takaku, F. (Eds.), Molecular Biology of Haematopoiesis, Vol. 3. Intercept, Andover, pp. 607-619.
37. Uzumaki H., Okabe T., Sasaki N., Hagiwara K., Takaku F., Tobita M., Yasukawa K., Ito S., Umezawa Y. Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells. Proc. Natl. Acad. Sci. USA. 86:1989;9323-9326.
38. Weiss M., Gross-Weege W., Harms B., Schneider E.M. Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. Cytokine. 8:1996;260-265.
39. Wright C.E., Rees D.D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26:1992;48-57.